CollPlant Biotechnologies (CLGN) Total Liabilities (2017 - 2025)

CollPlant Biotechnologies' Total Liabilities history runs 9 years deep, the most recent figure standing at $4.7 million for Q4 2025.

• Quarterly Total Liabilities fell 10.31% year-over-year to $4.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.7 million (down 10.31% YoY) and the FY2025 annual result came in at $4.7 million, down 10.31% from the prior year.
• Total Liabilities was $4.7 million for Q4 2025 at CollPlant Biotechnologies, down from $4.8 million in the prior quarter.
• Across five years, Total Liabilities topped out at $6.1 million in Q4 2021 and bottomed at $4.7 million in Q4 2025.
• A 5-year average of $5.4 million and a median of $5.5 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2023 — Total Liabilities increased 12.67% — and 2025, when it slipped 15.5%.
• CollPlant Biotechnologies' Total Liabilities stood at $6.1 million in 2021, then decreased by 10.09% to $5.5 million in 2022, then increased by 5.45% to $5.8 million in 2023, then fell by 9.35% to $5.2 million in 2024, then fell by 10.31% to $4.7 million in 2025.
• Business Quant data shows CLGN's Total Liabilities at $4.7 million in Q4 2025, $4.8 million in Q3 2025, and $4.9 million in Q2 2025.